Retinopatía diabética

Vargas Ávila AJ, Sojo Padilla JR, Campos Bonilla D. Diabetic retinopathy. Rev.méd.sinerg. [Internet]. 2022Jan.1 [cited 2024Jul.3];7(1):e750. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/750

Abstract

Diabetic retinopathy is the most common complication of diabetes. In most patients, retinopathy develops 10 to 15 years after the diagnosis of diabetes.
With the increasing prevalence of diabetes, more people are at risk for retinopathy. By 2045, 629 million people are expected to have diabetes globally.
By 2010, diabetic retinopathy was responsible for 3.7 million cases of visual problems and more than 833,000 cases of blindness.
The diagnosis of diabetic retinopathy relies on the detection of microvascular lesions.
Treatment of diabetic retinopathy remains a challenge, as existing treatments may fail and fail to achieve clinically meaningful visual improvement.
Therefore, there is an urgent need to develop new treatments that are more effective.

https://doi.org/10.31434/rms.v7i1.750

Keywords

diabetic retinopathy. diabetes. proliferative diabetic retinopathy. non-proliferative diabetic retinopathy. macular edema. retina. photocoagulation.

PDF (Español (España))

XPS (Español (España))

JPG (Español (España))

References

Petersmann A MWDMULRNMFGea. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2019;: p. s1-7.

Silvio E Inzucchi MBLM. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults. UpToDate. 2021.

Skyler JS BGBEDTERGLea. Differentiation of diabetes by pathophysiology, natural history and prognosis. Diabetes. 2017; 66(241-55).

MD PsS. Diabetic retinopathy: pathogenesis. Uptodate. 2021;(30).

Rio Sd. Tamizaje en el diagnostico y prevalencia de retinopatia diabetica en atencion primaria. revista medica chile. 2017; 145(564-571).

Rodríguez ML PSMMSDMOÁ. Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies. Oxid Med Cell Longev. 2019.

Calderon GD JOHGPSDlCZ. Oxidative stress and diabetic retinopathy: development abd treatment. [Online]; 2017. Acceso 02 de octubrede 2021. Disponible en: www.nature.com/eye.

Rossino MG CG. Nutraceuticals for the Treatment of Diabetic Retinopathy. nutrients. 2019; 11(771).

Colin A. McCannel MAMBGEHPSJKMBCLMRBRMRFSMJKSM. Retina and Vitreous. En American Academy of Ophthalmology. Basic and clinical sciencie course, Retina and Vitreous. San Francisco ; 2019-2020. p. 91-120.

Claire E Fraser MPDJDMARSM. UpToDate. [Online].; 2019. Acceso 02 de octubre de 2021. Disponible en: https://www-uptodate.com.

El Rami H BRSJSP. Evidence-Based Treatment of Diabetic Retinopathy. Seminars in Ophthalmology. 2016.

David K McCulloch M. UpToDate. [Online]; 2021. Acceso 17 de octubrede 2021. Disponible en: https://www.uptodate.com.

Jennifer K. Sun LMJ. The Diabetic Retinopathy Clinical Research Network and its Contributions to the Treatment of Diabetic Retinopathy. Ophthalmic Research. 2019; 62(225-230).

Wang W LA. Diabetic Retinopathy: Pathophysiology and Treatments. International Journal of Molecular Sciences. 2018; 19(1816).

F. Serrano FMACARSRCC. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. ELSEVIER. 2019; 11(1086).